Publicacions en col·laboració amb investigadors/es de University Hospital Bonn (46)

2024

  1. Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile

    Neuro-oncology, Vol. 26, Núm. 9, pp. 1723-1737

  2. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Monitoring the clinical practice of palliative sedation (PALSED) in patients with advanced cancer: an international, multicentre, non-experimental prospective observational study protocol

    BMC Palliative Care, Vol. 22, Núm. 1

  3. Palliative sedation terminology: Initial findings from a literature search and Delphi consensus procedure

    The role of Palliative Sedation in palliative care (Palliative Sedation), pp. 13 - 19

2022

  1. An analysis of the experiences of bereaved relatives and health care providers following palliative sedation: a study protocol for a qualitative international multicenter case study

    BMC Palliative Care, Vol. 21, Núm. 1

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Clinical Aspects of Palliative Sedation in Prospective Studies. A Systematic Review

    Journal of Pain and Symptom Management, Vol. 61, Núm. 4, pp. 831-844.e10

  2. How to measure the effects and potential adverse events of palliative sedation? An integrative review

    Palliative Medicine, Vol. 35, Núm. 2, pp. 295-314

2020

  1. Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes

    Cancer Discovery, Vol. 10, Núm. 7, pp. 942-963

2018

  1. Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

    Open Forum Infectious Diseases, Vol. 5, Núm. 1

  2. Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial

    Cancer Cell, Vol. 33, Núm. 5, pp. 829-842.e5

2017

  1. CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: A multinational, multicohort European study

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 10, pp. 2869-2878

2016

  1. Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy

    HIV Medicine, Vol. 17, Núm. 6, pp. 471-478

  2. Infection-related and -unrelated malignancies, HIV and the aging population

    HIV Medicine, Vol. 17, Núm. 8, pp. 590-600

2015

  1. Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study

    HIV Medicine, Vol. 16, Núm. 9, pp. 533-543

  2. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

  3. Hepatitis C seroconversions in HIV infection across Europe: Which regions and patient groups are affected?

    Liver International, Vol. 35, Núm. 11, pp. 2384-2391

2014

  1. A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe

    Infection, Vol. 42, Núm. 4, pp. 757-762

  2. Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study

    BMC Nephrology, Vol. 15, Núm. 1